Award
Delivery Order #SPE2DR26FBQAV
Delivery Order for Pharmaceutical Supply of EXPAREL Vials to Federal Agency
Buyer
Defense Logistics Agency
Award Amount
$6,164.64
Ceiling
$6,164.64
Awarded
March 06, 2026
Period of Performance
Mar 06, 2026 – Mar 27, 2026
Identifier
SPE2DR26FBQAV
NAICS
424210
This contract represents a delivery order awarded under an existing indefinite delivery vehicle (IDV) held by DMS Pharmaceutical Group Inc., a recognized pharmaceutical distributor. The order procures specific pharmaceutical products, namely EXPAREL 133 MG/10 ML vials, which are critical for therapeutic applications. The significance of this contract lies in supporting federal healthcare operations through the timely supply of essential medications, thus sustaining patient care quality. Scope of work includes the delivery of these pharmaceutical vials to the designated location within a few weeks, ensuring rapid fulfillment of agency medical supply requirements. This task order is part of a multi-year strategic supply agreement previously competitively awarded, emphasizing DMS Pharmaceutical Group's trusted role in pharmaceutical logistics. The performance period for this delivery is short-term, reflecting a prompt response need within the broader contract framework.
Description
4571102544!EXPAREL 133 MG/10 ML VIAL 10ML